InvestorsHub Logo
Followers 99
Posts 3449
Boards Moderated 0
Alias Born 03/05/2014

Re: None

Sunday, 03/30/2014 6:17:29 PM

Sunday, March 30, 2014 6:17:29 PM

Post# of 30331
ITNS!! SOME IMPORTANT DD:



About 2 1/2 years ago ITNS created a pharmaceutical division. They brought on board the Famous Dr Charles Hensley.. The great doctor is the founder and Creator of ZICAM cold Remedy. I am sure you have heard of it. Well about 2 1/2 years ago Dr Hensley who is a Homeopathic Genius embarked on this great product and Idea. It's called Emesyl. Emesyl treats nausea brought on by all sorts of illnesses. One in Particular is Chemo Therapy. Most people who suffer from Nausea cannot take medicine Orally because they Vomit it up. Dr Hensley has created a Nasal Passage treatment. It has already went through all the testing needed. It has all the packaging done. Emesyl is ready for Manufacturing and distribution. It is Patented and will be granted in 2 weeks.

Dr Hensley because of ZICAM already has all the connections to get into every Big Box store we desire.

Next we all were shocked and very happy that Dr Hensley and ITNS have decided to also get into the Medical Marijuana business as well. California law allows Medical Marijuana and it's also a homeopathic drug. We don't know yet all the details but what ever is coming is going to be huge based on our recent licensing deal with MYEC that gives us total control of Southern California.

It is also anticipated that ITNS is on their way or will be creating a Nasal based Marijuana drug to help fight Tumor treatments and other illnesses when folks are too sick to smoke it. They will be able to inject in through there nasal passages. This is pure speculation but many feel it's in the works.

Lastly Company Officials own about 35-45% of the shares restricted.

I hope this gives you a great start on your DD of ITNS.

WE HAVE A GEM HERE!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.